Peer-influenced content. Sources you trust. No registration required. This is HCN.

Cleveland Clinic Journal of MedicineWhat are the Treatment Options for Myasthenia Gravis if First-line Agents Fail?

Consider immunosuppressive therapy in patients on adequate acetylcholinesterase inhibitor therapy who do not demonstrate significant benefit. This article discusses the assessment of therapeutic failure, steroidal therapy, when to consider nonsteroidal anti-inflammatory therapy, and recommendations for monitoring treatment.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form